About Advancing RNA
Our Readers
Advancing RNA attracts innovators and leaders in RNA therapeutics, including scientists, R&D managers, regulatory affairs specialists, quality assurance professionals, manufacturing directors, and biotech executives. This community dives into the complexities of RNA drug development, from overcoming manufacturing hurdles to navigating regulatory landscapes, offering a hub for advancing knowledge and collaboration in the field.
Meet the Chief Editor: Anna Rose Welch
Anna Rose Welch leads Advancing RNA as editorial and community director, creating thought leadership content and hosting discussions on RNA therapeutics. She engages with industry leaders and is a regular at top conferences like RNA Connect and BioPhorum ATMP.
Previously, Anna Rose was chief editor of Biosimilar Development, building a global following in biologics. Her work has taken her worldwide to moderate panels, chair conferences, and advise on biologics policies.
Outside of work, she is a published poet, violinist, and aspiring ballet dancer.
Related Communities
Let's work together.
Whether you're ready to hit the ground running or just starting and have questions, we're here to understand your goals and explore how we can help you.